GLOBUS MEDICAL INC
GMEDNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for GMED. That does not mean none is planned.
Get an email about GMED's next catalysts
Track GLOBUS MEDICAL (GMED) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
Market Overview
Stock performance and key metrics
Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.
WebsiteNo drugs found in this phase.
Frequently asked questions
When is GLOBUS MEDICAL INC's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for GLOBUS MEDICAL INC (GMED) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track GMED biotech catalysts?→
Add GMED to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow GLOBUS MEDICAL INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.